Semaphorin 3F (SEMA3F) influences patient survival in esophageal adenocarcinoma.
Knipper K, Lyu SI, Jung JO, Alich N, Popp FC, Schröder W, Fuchs HF, Bruns CJ, Quaas A, Nienhueser H, Schmidt T.
Knipper K, et al. Among authors: lyu si.
Sci Rep. 2024 Sep 4;14(1):20589. doi: 10.1038/s41598-024-71616-8.
Sci Rep. 2024.
PMID: 39232098
Free PMC article.